Company
Amberstone Biosciences
Discovering Transformative Immunotherapeutics
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Founded in 2018, an emerging biotherapeutics company focused on developing novel tumor microenvironment-activated immunotherapies to treat solid cancers
Loading relationship preview